Mercator Medical (WAR:MRC) Total Stockholders Equity: zł918.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MRC Mercator Medical SA WAR:MRC
63 GF Score
Price zł58.50
GF Value zł52.11
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Mercator Medical Total Stockholders Equity?

Mercator Medical WAR:MRC +1.04% 63 Total Stockholders Equity is zł918.1 Mil as of Mar. 2026. GuruFocus rates WAR:MRC with a GF Score™ of 63/100 and a GF Value™ of zł52.11 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Mercator Medical's Total Stockholders Equity for the quarter that ended in Mar. 2026 was zł918.1 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Mercator Medical's Book Value per Share for the quarter that ended in Mar. 2026 was zł100.39. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Mercator Medical's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.02.

Mercator Medical  (WAR:MRC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Mercator Medical's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(918.058-0)/9.145
=100.39

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Mercator Medical's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(6.282 + 16.544) / 918.058
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Total Stockholders Equity Related Terms

Mercator Medical Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Total Stockholders Equity Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,143.85 1,008.73 862.09 920.92 904.22

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 920.87 894.39 893.11 904.22 918.06
WAR:MRC
63GF Score
Mercator Medical SA WAR:MRC
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of zł918.1 Mil mean?
Mercator Medical (WAR:MRC) has a Total Stockholders Equity of zł918.1 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Mercator Medical and its competitors.
Is Mercator Medical's Total Stockholders Equity too high?
Mercator Medical's current Total Stockholders Equity is zł918.1 Mil. Overall, Mercator Medical has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Total Stockholders Equity compare to ISRG and BDX?
Mercator Medical's Total Stockholders Equity of zł918.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Mercator Medical and its competitors. Mercator Medical's current Total Stockholders Equity is zł918.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (WAR:MRC) is currently considered Modestly Overvalued. The stock's GF Value™ is zł52.11, compared to a current price of zł58.50 — trading 12.3% above its estimated fair value. The current Total Stockholders Equity is zł918.1 Mil. Mercator Medical's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Mercator Medical (WAR:MRC), the current Total Stockholders Equity is zł918.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (WAR:MRC) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of zł58.50 is trading 12.3% above its estimated GF Value™ of zł52.11. GuruFocus considers Mercator Medical to be Modestly Overvalued.

Key valuation signals for WAR:MRC:

  • Total Stockholders Equity: zł918.1 Mil
  • GF Value™: zł52.11 vs. price of zł58.50 (12.3% above fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the WAR:MRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MM2:Germany
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
63GF Score

Get the complete analysis for WAR:MRC

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł58.50
Price
zł52.11
GF Value